| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 03/17/2009 | CA2258882C Compositions and methods for altering the biodistribution of biological agents |
| 03/12/2009 | WO2009032752A2 Multimodal nanoparticles for non-invasive bio-imaging |
| 03/12/2009 | WO2009032160A2 Metalloprotein mri contrast agents and related methods |
| 03/12/2009 | WO2009031890A2 A carrier particle for use in bio-applications |
| 03/12/2009 | WO2009031712A1 Compound, diagnostic agent, nuclear magnetic resonance analysis method, nuclear magnetic resonance imaging method, mass spectrometry method and mass spectrometry imaging method |
| 03/12/2009 | WO2009031593A1 Contrast agent containing silsesquioxane |
| 03/12/2009 | WO2009030058A1 Device, gas mixture and method for lung diagnosis |
| 03/12/2009 | WO2009013692A3 Multimodality matching medium for diffuse optical tomography and ultrasound measurements |
| 03/12/2009 | WO2008133641A3 Antibodies directed to gpnmb and uses thereof |
| 03/12/2009 | US20090070890 Product |
| 03/12/2009 | US20090069225 Somatostatin analogues |
| 03/12/2009 | US20090068636 Viral protein |
| 03/12/2009 | US20090068115 Amine Functionalized Superparamagnetic Nanoparticles for the Synthesis of Bioconjugates and Uses Therefor |
| 03/12/2009 | US20090068114 Noninvasive Thermometry Monitoring System |
| 03/12/2009 | US20090068113 Amphiphilic squaraine dyes, process for preparation thereof and use thereof |
| 03/12/2009 | US20090068112 Magnetic Nanoparticles for Imaging |
| 03/12/2009 | US20090068110 Antibodies to insulin-like growth factor receptor |
| 03/12/2009 | US20090068109 Anti-mcp-1 antibodies, compositions, methods and uses |
| 03/12/2009 | US20090068108 Biospecific contrast agents |
| 03/12/2009 | US20090068107 Enzyme regulating ether lipid signaling pathways |
| 03/12/2009 | US20090068106 selectively inhibit alpha v beta 3 integrin; used in the treatment of diseases associated with angiogenesis and cancer |
| 03/12/2009 | US20090068104 Substantially Homogeneous Bio-Affecting Material Having a Pre-Determined Ratio of Bioaffecting Component to Cell Targeting Component, the Method for Making Such a Material and the Method of its use |
| 03/12/2009 | US20090068097 Method for non-invasive detection and treatment of cerebral aneurysms |
| 03/12/2009 | DE102004061348B4 Verfahren zur Auswahl eines geeigneten Kontrastmittels A process for the selection of a suitable contrast agent |
| 03/12/2009 | CA2698945A1 Contrast agent containing silsesquioxane |
| 03/11/2009 | EP2033663A1 Saccharidic fluorescent substrates, method of preparing same and use of same |
| 03/11/2009 | EP2033661A1 Methods of screening affinity marker libraries |
| 03/11/2009 | EP2032981A2 Screen for inflammatory response molulators |
| 03/11/2009 | EP2032594A1 Glycyrrhetinic acid derivatives |
| 03/11/2009 | EP2032041A1 Method, materials and apparatus for investigating asthma using dust mite allergen |
| 03/11/2009 | EP2032017A2 Method and device for optical detection of the eye |
| 03/11/2009 | CN101380478A Installation method of fluorescent visual high-transfer human liver cancer nude mouse model |
| 03/11/2009 | CN100467604C Chimeric GFP-aequorin as bioluminescent ca<++> reporters at the single cell level |
| 03/11/2009 | CN100467543C Fluorinated dyes or colorants and their uses |
| 03/11/2009 | CN100467067C Medium for contrast enhancement or convenience for ultrasonic, endoscopic, and other medical examinations |
| 03/10/2009 | US7502649 Gastrointestinal methods and apparatus for use in treating disorders |
| 03/10/2009 | US7501506 Pentopyranosyl nucleic acid does not non-covalently bond or hybridize to naturally occurring DNA or RNA; conjugated through a covalent linkage to the biotin molecule; diagnosis, gene therapy |
| 03/10/2009 | US7501498 Moncolonal antibody for use in diagnosis and treatment of cell proliferative disorders; immunotherapy; tissue engineering |
| 03/10/2009 | US7501399 Immunoeffector compounds |
| 03/10/2009 | US7501395 Method of screening for antianxiety drugs |
| 03/10/2009 | US7500953 High contrast optoacoustic imaging using nanoparticles |
| 03/10/2009 | CA2342210C Thiazoline acid derivatives |
| 03/05/2009 | WO2009029464A1 Removal of silica from water soluble compounds by nanofiltration and reverse phase chromatography |
| 03/05/2009 | WO2009028420A1 Agent for improving coronary artery extractability |
| 03/05/2009 | WO2009027937A2 Clustered magnetic particles as tracers for magnetic particle imaging |
| 03/05/2009 | WO2009027690A1 Diagnostic agent |
| 03/05/2009 | WO2009027388A2 Imaging medium comprising hyperpolarised 13c-acetate and use thereof |
| 03/05/2009 | WO2009027106A2 Non-invasive in vivo imaging and methods for treating type i diabetes |
| 03/05/2009 | WO2008084028A3 Coated barium sulphate nanoparticles as contrast agent |
| 03/05/2009 | US20090062876 Quantum dot labeled stem cells for use in providing pacemaker function |
| 03/05/2009 | US20090060865 Mammalian receptor proteins; related reagents and methods |
| 03/05/2009 | US20090060846 nanoparticle having a core comprising a magnetic material and surface to which are covalently coupled a plurality of silane moieties |
| 03/05/2009 | US20090060845 Diagnosis substance for application in a method to diagnosis pathological tissue and a method for production of such a diagnosis substance |
| 03/05/2009 | US20090060844 Method and contrast agent for imaging a prostate tumor |
| 03/05/2009 | US20090060843 Non-Invasive In Vivo Imaging and Methods for Treating Type I Diabetes |
| 03/05/2009 | US20090060842 Method for diagnosis and treatment of prostatitis |
| 03/05/2009 | US20090060840 Lanthanide Nanoparticle Conjugates and Uses Thereof |
| 03/05/2009 | US20090060839 Gold Nanoparticle Conjugates and Uses Thereof |
| 03/05/2009 | US20090060836 Derivatives of 2-nitro-1,3-imidazole coupled to amino acids and deoxyribose useful for the detection of hypoxic biological tissue |
| 03/05/2009 | DE102007041836A1 Verfahren zur Abbildung eines Prostatatumors und dafür geeignetes Kontrastmittel Method for imaging a prostate tumor and for suitable contrast agent |
| 03/05/2009 | DE102007041831A1 Kontrastmitttel für die Ultraschalluntersuchung der Prostata und Verfahren zur Diagnose von Prostatakrebs Kontrastmitttel for the ultrasonic examination of the prostate and method for the diagnosis of prostate cancer |
| 03/05/2009 | CA2697361A1 Alpha-synuclein binding diagnostic agent |
| 03/04/2009 | EP2030634A1 Medicament for and method of treatment of prostate cancer |
| 03/04/2009 | EP2030633A1 Contrast agent for ultrasound diagnostics of the prostate and methods of diagnosis of prostate cancer |
| 03/04/2009 | EP2030632A1 A carrier particle for use in bio-applications |
| 03/04/2009 | EP2030630A1 Method for removing a prostate tumour and suitable contrasting agent |
| 03/04/2009 | EP2029754A1 Magnetosome gene expression in eukaryotic cells |
| 03/04/2009 | EP2029481A1 Biomedical materials |
| 03/04/2009 | EP2029180A2 Compositions and methods for diagnosis of axial pain with or without radiculopathy |
| 03/04/2009 | EP1088062B1 Transplants for myocardial scars |
| 03/04/2009 | EP1019085B1 Non-anaphylactic forms of allergens and their use |
| 03/04/2009 | CN101379023A Contrast agents |
| 03/04/2009 | CN101378785A Compositions comprising magnetic iron oxide particles and use thereof in medical imaging |
| 03/04/2009 | CN101378784A Method to produce hyperpolarised carboxylates |
| 03/04/2009 | CN101378665A Food and process for producing food |
| 03/03/2009 | US7498417 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
| 03/03/2009 | US7498129 Measuring changes in level of antigen recognizable by a monoclonal antibody or antigen binding fragment; monoclonal antibody is produced by hybridoma cell line; decreased level indicates a reduced tumor; diagnosis, cell purification |
| 03/03/2009 | US7498018 barium sulfate solutions of various concentrations for devices imaging the gastrointestial tract |
| 02/26/2009 | WO2009026315A2 Use of carbon nanotube for drug delivery |
| 02/26/2009 | WO2009025168A1 Sugar-modified liposome containing compound for contrast agent and contrast agent |
| 02/26/2009 | WO2009023961A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 02/26/2009 | WO2008139207A3 Labelled hgf binding peptides for imaging |
| 02/26/2009 | WO2008045604A3 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 02/26/2009 | WO2008036117A3 Nanogel contrast agents for optical molecular imaging |
| 02/26/2009 | WO2007093451A3 Multimodal imaging using a three compartment polymer nanoparticle with cell specificity |
| 02/26/2009 | US20090053248 Compositions and methods for transepithelial molecular transport |
| 02/26/2009 | US20090053247 Biological materials and uses thereof |
| 02/26/2009 | US20090053142 Contrast agents |
| 02/26/2009 | US20090053141 Compositions and methods for magnetic resonance imaging contrast agents |
| 02/26/2009 | US20090053140 METHODS OF IDENTIFYING GENES INVOLVED IN MEMORY FORMATION USING SMALL INTERFERING RNA(siRNA) |
| 02/26/2009 | US20090053139 Dendrimer based compositions and methods of using the same |
| 02/26/2009 | US20090053138 Stabilized Aptamers to Platelet Derived Growth Factor and their Use as Oncology Therapeutics |
| 02/26/2009 | US20090053137 Chelating Conjugates Having a Substituted Aromatic Moiety and Derivatives Thereof |
| 02/26/2009 | DE102007039454A1 Quantifying absorption of radiotracer in body part of patient for positron-emission-tomography measurement, comprises quantifying absorption of radiotracer using a permeability information related to blood vessel permeability of patient |
| 02/26/2009 | CA2697093A1 Use of carbon nanotube for drug delivery |
| 02/26/2009 | CA2696684A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP2026844A2 Novel imaging agents |
| 02/25/2009 | EP2026840A2 Targeted imaging and/or therapy using the [3+2]-azide-alkyne cycloaddition |
| 02/25/2009 | EP1572246B1 Novel compositions of magnetic particles covered with gem-bisphosphonate derivatives |